MAIA Biotechnology
MAIA
17 hedge funds and large institutions have $4.15M invested in MAIA Biotechnology in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 6 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
2.05% less ownership
Funds ownership: 8.19% → 6.14% (-2.1%)
19% less funds holding
Funds holding: 21 → 17 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
77% less capital inflows, than outflows
Capital inflows: $293K | Capital outflows: $1.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$112K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$91.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$52K |
| 4 |
XTX Topco
George Town,
Cayman Islands
|
+$34.3K |
| 5 |
BlackRock
New York
|
+$3.76K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Halter Ferguson Financial
Carmel,
Indiana
|
-$1.08M |
| 2 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$56.3K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
-$52.6K |
| 4 |
Jane Street
New York
|
-$40.8K |
| 5 |
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$36.9K |
MAIA Hedge Fund Activity: Q3 2024 in Review
17 of the 6,986 institutional investors tracked by Wall St. Rank reported a position in MAIA Biotechnology (MAIA) for Q3 2024, worth a combined $4.15M — down 32% from $6.09M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of MAIA and 2 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 6 added.
The largest buyer was Geode Capital Management, adding an estimated $112K. The largest seller was Halter Ferguson Financial, cutting an estimated $1.08M.
- 17 institutional investors held MAIA Biotechnology (MAIA) as of Q3 2024, down from 21 in Q2 2024.
- Funds reported $4.15M of MAIA Biotechnology stock for Q3 2024, down 32% quarter-over-quarter.
- 2 funds opened new MAIA Biotechnology positions in Q3 2024 and 6 closed out, a net change of -4 holders.
- The largest MAIA Biotechnology buyer in Q3 2024 was Geode Capital Management, an estimated $112K added.
- The largest MAIA Biotechnology seller in Q3 2024 was Halter Ferguson Financial, an estimated $1.08M sold.
Based on aggregated 13F filings for Q3 2024.